Effect of Organic Anion Transporting Polypeptide 1B1 on Plasma Concentration Dynamics of Clozapine in Patients with Treatment-Resistant Schizophrenia
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252313228 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Toshihiro Sato und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Tohoku University Hospital, Sendai 980-8574, Japan. Hauptthemen laut MEDLINE: Clozapine, Polymorphism, Single Nucleotide, Liver-Specific Organic Anion Transporter 1, Molecular Docking Simulation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Clinical Research Promotion Program for Young Investigators of Tohoku University Hospital, Research grant from Japan Research Foundation for Clinical Pharmacology, Japan Research Foundation for Clinical Pharmacology, Tokyo, Japan.
Abstract (Originalsprache)
The involvement of drug-metabolizing enzymes and transporters in plasma clozapine (CLZ) dynamics has not been well examined in Japanese patients with treatment-resistant schizophrenia (TRS). Therefore, this clinical study investigated the relationship between single nucleotide polymorphisms (SNPs) of various pharmacokinetic factors (drug-metabolizing enzymes and transporters) and dynamic changes in CLZ. Additionally, we aimed to determine whether CLZ acts as a substrate for pharmacokinetic factors using in vitro assays and molecular docking calculations. We found that 6 out of 10 patients with TRS and with multiple organic anion transporting polypeptide (OATP) variants (OATP1B1: *1b, *15; OATP1B3: 334T>G, 699G>A; and OATP2B1: *3, 935G>A, 601G>A, 76_84del) seemed to be highly exposed to CLZ and/or N-desmethyl CLZ. A CLZ uptake study using OATP-expressing HEK293 cells showed that CLZ was a substrate of OATP1B1 with Km and Vmax values of 38.9 µM and 2752 pmol/mg protein/10 min, respectively. The results of molecular docking calculations supported the differences in CLZ uptake among OATP molecules and the weak inhibitory effect of cyclosporine A, which is a strong inhibitor of OATPs, on CLZ uptake via OATP1B1. This is the first study to show that CLZ is an OATP1B1 substrate and that the presence of SNPs in OATPs potentially alters CLZ pharmacokinetic parameters.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, Tohoku University Hospital, Sendai 980-8574, Japan.
- Graduate School of Information Sciences, Tohoku University, Sendai 980-8578, Japan.
- Faculty of Pharmaceutical Sciences, Tohoku University, Sendai 980-8578, Japan.
- Department of Psychiatry, Tohoku University Hospital, Sendai 980-8574, Japan.
- Department of Psychiatry, Graduate School of Medicine, Tohoku University, Sendai 980-8575, Japan.
- Advanced Research Center for Innovations in Next-Generation Medicine, Tohoku University, Sendai 980-8573, Japan.
ORCID-Profile: Toshihiro Sato, Takeshi Kawabata, Masaki Kumondai, Hiroshi Komatsu, Yuki Kikuchi, Yu Sato, Kei Nanatani, Masahiro Hiratsuka, Masamitsu Maekawa, Hiroaki Yamaguchi, Hiroaki Tomita
Förderung
- The Clinical Research Promotion Program for Young Investigators of Tohoku University Hospital
- Research grant from Japan Research Foundation for Clinical Pharmacology
- Japan Research Foundation for Clinical Pharmacology, Tokyo, Japan
Zitieren
APA
Sato, T., Kawabata, T., Kumondai, M., Hayashi, N., Komatsu, H., Kikuchi, Y., Onoguchi, G., Sato, Y., Nanatani, K., Hiratsuka, M., Maekawa, M., Yamaguchi, H., Abe, T., Tomita, H., & Mano, N. (2024). Effect of Organic Anion Transporting Polypeptide 1B1 on Plasma Concentration Dynamics of Clozapine in Patients with Treatment-Resistant Schizophrenia. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252313228
Vancouver
Sato T, Kawabata T, Kumondai M, Hayashi N, Komatsu H, Kikuchi Y, et al. Effect of Organic Anion Transporting Polypeptide 1B1 on Plasma Concentration Dynamics of Clozapine in Patients with Treatment-Resistant Schizophrenia. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252313228
BibTeX
@article{Sato2024,
author = {Sato, Toshihiro and Kawabata, Takeshi and Kumondai, Masaki and Hayashi, Nagomi and Komatsu, Hiroshi and Kikuchi, Yuki and Onoguchi, Go and Sato, Yu and Nanatani, Kei and Hiratsuka, Masahiro and Maekawa, Masamitsu and Yamaguchi, Hiroaki and Abe, Takaaki and Tomita, Hiroaki and Mano, Nariyasu},
title = {Effect of Organic Anion Transporting Polypeptide 1B1 on Plasma Concentration Dynamics of Clozapine in Patients with Treatment-Resistant Schizophrenia},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252313228}
}
EUVIMED